American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 2013. ,
, World Alzheimer Report, 2015.
Alzheimer's Dis Int, pp.1-92, 2015. ,
Dementia prevention, intervention, and care, Lancet, vol.390, pp.2673-734, 2017. ,
Age, vascular health, and Alzheimer disease biomarkers in an elderly sample, Ann Neurol, vol.82, issue.5, pp.706-724, 2017. ,
A Short History of Blood Pressure Measurement, J R Soc Med, vol.70, issue.11, pp.793-802, 1977. ,
The Evolution of Clinical Sphygmomanometry, Bull N Y Acad Med, vol.17, issue.11, pp.871-81, 1941. ,
90th Anniversary of the Development by Nikolai S. Korotkoff of the Auscultatory Method of Measuring Blood Pressure. Circulation, vol.94, pp.116-124, 1996. ,
An Address ON HIGH BLOOD PRESSURE: ITS ASSOCIATIONS, ADVANTAGES, AND DISADVANTAGES: Delivered at the Glasgow Southern Medical Society, Br Med J, vol.2, pp.1173-1180, 1912. ,
The general adaptation syndrome and the diseases of adaptation, J Allergy, vol.17, p.231, 1946. ,
, Kotchen -2011 -Historical Trends and Milestones in Hypertension
Incidence of Hypertension and Educational Attainment The NHANES I Epidemiologic Followup Study, Am J Epidemiol, vol.152, issue.3, pp.272-280, 2000. ,
The Framingham Heart Study and the epidemiology of cardiovascular disease: A historical perspective, Lancet, vol.383, issue.9921, pp.999-1008, 2014. ,
Coronary heart disease in the Framingham study, Am J Public Health Nations Health, vol.47, issue.4, pp.4-24, 1957. ,
Blood Pressure, Systolic and Diastolic, and Cardiovascular Risks: US Population Data, Arch Intern Med, vol.153, issue.5, pp.598-615, 1993. ,
Prise en charge de l'hypertension artérielle de l'adulte, 2016. ,
, Évaluation des technologies de santé. Analyse Médico-économique. Évaluation par classe des médicaments antihypertenseurs, pp.1-250, 2013.
, prévalence, traitement et contrôle en 2015 et évolutions depuis 2006, vol.10, pp.170-179, 2018.
Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries, Circulation, vol.134, issue.6, pp.441-50, 2009. ,
Chapter 1 -The "First" Case, pp.3-5, 2016. ,
, , 2016.
The Clinical Dementia Rating (CDR): current version and scoring rules, Neurology, vol.43, issue.11, pp.2412-2416, 1993. ,
Mini-mental state": A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, vol.12, issue.3, pp.189-98, 1975. ,
Chapter 2 -Clinical Appearance, Progression, and Classification, pp.7-23, 2016. ,
The amyloid hypothesis of Alzheimer's disease at 25 years, EMBO Mol Med, vol.8, issue.6, pp.595-608, 2016. ,
Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol, vol.82, issue.4, pp.239-59, 1991. ,
Update on cerebral small vessel disease: A dynamic whole-brain disease, Stroke and Vascular Neurology, vol.1, 2016. ,
Small vessel disease: mechanisms and clinical implications, Lancet Neurol, vol.18, issue.7, pp.684-96, 2019. ,
White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities. Alzheimer's Dement, Transl Res Clin Interv, vol.5, pp.107-124, 2019. ,
The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: Systematic review and meta-analysis, BMJ, vol.341, issue.7767, p.288, 2010. ,
Cerebral small vessel disease and the risk of dementia: A systematic review and meta-analysis of population-based evidence, vol.14, pp.1482-92, 2018. ,
Amyloid biomarkers in Alzheimer's disease, Trends Pharmacol Sci, vol.36, issue.5, pp.297-309, 2015. ,
CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease, Brain, vol.129, issue.11, pp.3035-3076, 2006. ,
Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease, Neurology, 1991. ,
The cortical signature of Alzheimer's disease: Regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals, Cereb Cortex, vol.19, issue.3, pp.497-510, 2009. ,
Resting state FDG-PET functional connectivity as an early biomarker of Alzheimer's disease using conjoint univariate and independent component analyses, Neuroimage, vol.63, issue.2, pp.936-982, 2012. ,
Age-related deficit accumulation and the risk of latelife dementia. Alzheimer's Res Ther, vol.6, pp.5-8, 2014. ,
Brain reserve and the prevention of dementia, Curr Opin Psychiatry, vol.21, issue.3, pp.296-302, 2008. ,
Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers, Lancet Neurol, vol.12, issue.2, pp.207-223, 2013. ,
,
, Concomitant vascular and neurodegenerative pathologies double the risk of dementia
, , vol.14, pp.148-56, 2018.
Mixed brain pathologies account for most dementia cases in community-dwelling older persons, Neurology, vol.69, pp.2197-204, 2007. ,
,
Alzheimer et autres démences à partir des bases de données médico-administratives ? Comparaison aux données de cohortes populationnelles, Bull Epidémiol Hebd, pp.459-67, 2016. ,
Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study, Neurology, vol.78, pp.1456-63, 2012. ,
Twenty-year changes in dementia occurrence suggest decreasing incidence in central, Neurology, vol.80, issue.20, pp.1888-94, 2013. ,
A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II, Nat Commun, vol.7, p.11398, 2016. ,
Prevalence of dementia in a southern European population in two different time periods: the ZARADEMP Project, Acta Psychiatr Scand, vol.116, issue.4, pp.299-307, 2007. ,
Évolution temporelle des démences : état des lieux en France et à l'international, Bull Epidémiol Hebd, pp.467-73, 2016. ,
Relationships among clinic, home, and ambulatory blood pressures with small vessel disease of the brain and functional status in older people with hypertension, Am Heart J, vol.205, pp.21-30, 2018. ,
, Impact of Hypertension on Cognitive Function, vol.68
Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults, Nature, vol.555, issue.7696, pp.377-81, 2018. ,
The Prevention of Dementia With Antihypertensive Treatment: New Evidence From the Systolic Hypertension in Europe (Syst-Eur) Study, Arch Intern Med, vol.162, issue.18, pp.2046-52, 2002. ,
Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies, Lancet Neurol, vol.19, issue.1, 2019. ,
Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial, JAMA -J Am Med Assoc, vol.321, issue.6, pp.553-61, 2019. ,
Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease, Nat Rev Neurosci, vol.18, issue.7, pp.419-453, 2017. ,
Cognitive and imaging markers in non-demented subjects attending a memory clinic: Study design and baseline findings of the MEMENTO cohort, vol.9, pp.1-13, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-01580853
, L'épreuve de rappel libre/rappel indicé à 16 items (RL/RI-16), 2004.
A largescale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity, NeuroImage Clin, vol.11, pp.802-814, 2016. ,
Amyloid-? 42/40 Cerebrospinal Fluid Concentration Ratio in the Diagnostics of Alzheimer's Disease: Validation of Two Novel Assays, J Alzheimer's Dis, vol.43, pp.183-91, 2015. ,
, , 2011.
, Expert Consensus Document on Hypertension in the Elderly: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents Developed in Collaboration With the American Academy of Neurology, American. J Am Coll Cardiol, vol.57, issue.20, pp.2037-114, 2011.
Handling Missing Data With Multilevel Structural Equation Modeling and Full Information Maximum Likelihood Techniques ,
, Res Nurs Health, vol.39, issue.4, pp.286-97, 2016.
The effect of white matter hyperintensities on cognition is mediated by cortical atrophy, Neurobiol Aging, vol.64, pp.25-32, 2018. ,
Toward a biological definition of Alzheimer's disease. Alzheimer's Dement, vol.14, pp.535-62, 2018. ,
Vascular dysfunction-The disregarded partner of Alzheimer's disease. Alzheimer's Dement, vol.15, pp.158-67, 2019. ,
Cerebral microbleeds: Prevalence and relationship to amyloid burden, Neurology, vol.92, issue.3, pp.253-62, 2019. ,
White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease, Neurology, vol.94, issue.9, pp.950-60, 2020. ,